Where does this topic fit on TruTan
Tektons centralized services team delivered swift regulatory turnaround in under 24 hours, eliminating delays and enabling the site to begin screening and enrollment almost immediately
Key limitations of current evidence include: Relatively short follow-up periods (typically 35 years) in randomised trials, whereas pancreatic cancer may take years to develop Potential for detection bias, as patients on GLP-1 therapy may undergo more frequent medical monitoring Difficulty accounting for all confounding factors in observational studies Despite these limitations, the weight of current evidence does not support a causal link between GLP-1 receptor agonist use and pancreatic cancer development
Williams, 43, said she started the weekly GLP-1 injections in early 2024, about six months after giving birth to her second daughter
They are intentionally confusing consumers, John Kuckelman, Novos general counsel and senior vice president, said in an interview
The microwave frequency was measured with an HP 5010 frequency counter
